Spinouts from the University of Oxford receive pre-money valuations that are on average £4m higher than their University of Cambridge counterparts but they are 2.5...
US biopharmaceutical company Gilead Sciences is acquiring Oxford-based biotech startup MiroBio in a cash deal valued at approximately $405m (£333.9m). Spun out of the University...